Redeye comments on Vicore’s Q3 report, which came in as expected. We slighly tweak our base case and expect a very exciting Q4 - most notably the second interim readout within IPF.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.